Nieren und Gefäße

Schlüsselwörter

Arteriosklerose - Hypertonie - Nierenfunktion - kardiovaskuläre Risikofaktoren

Key words

atherosclerosis - hypertension - kidney function - cardiovascular risk factors

Literatur

• 1 ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain.  Circulation. 2007;  115 402-26
• 2 Anavekar N S, McMurray J J, Velazquez E J, Solomon S D, Kober L, Rouleau J L. et al . Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.  N Engl J Med. 2004;  351 1285-95
• 3 Block G A, Hulbert-Shearon T E, Levin N W, Port F K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients.  Am J Kidney Dis. 1998;  31 607-17
• 4 Block G A, Klassen P S, Lazarus J M, Kooienga L, Spiegel D M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.  J Am Soc Nephrol. 2004;  15 2208-18
• 5 Go A S, Chertow G M, Fan D, McCulloch C E, Hsu C Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.  N Engl J Med. 2004;  351 1296-305
• 6 Goodman W G, Goldin J, Kuizon B D, Yoon C, Gales B, Sider D. et al . Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.  N Engl J Med. 2000;  342 1478-83
• 7 Gross M L, Meyer H P, Ziebart H. et al . Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients.  Clin J Am Soc Nephrol. 2007;  2 121-34
• 8 Ix J H, Shlipak M G, Sarnak M J, Beck G J. et al . Fetuin-A is not associated with mortality in chronic kidney disease.  Kidney Int. 2007;  72 1394-9
• 9 Jono S, McKee M D, Murry C E, Shioi A. et al . Phosphate regulation of vascular smooth muscle cell calcification.  Circ Res. 2000;  87 E10-E17
• 10 Kalantar-Zadeh K, Kuwae N, Regidor D L, Kovesdy C P, Kilpatrick R D. et al . Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.  Kidney Int. 2006;  70 771-80
• 11 Ketteler M, Biggar P H, Brandenburg V M, Schlieper G, Westenfeld R, Floege J. Epidemiologie, Pathophysiologie und Therapie der Calciphylaxie.  Dtsch Arztebl. 2007;  104 A 3481-5
• 12 Ketteler M, Bongartz P, Westenfeld R, Wildberger J E, Mahnken A H. et al . Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis.  Lancet. 2003;  361 827-33
• 13 Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon.  Hypertension. 2006;  47 1027-34
• 14 Lindner A, Charra B, Sherrard D J, Scribner B H. Accelerated atherosclerosis in prolonged maintenance hemodialysis.  N Engl J Med. 1974;  290 697-701
• 15 Moe S, Drüeke T, Cunningham J. et al . Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).  Kidney Int. 2006;  69 1945-53
• 16 Moe S M, Duan D, Doehle B P, O’Neill K D, Chen N X. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.  Kidney Int. 2003;  63 1003-11
• 17 Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U. et al . Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure.  Circulation. 2002;  106 100-5
• 18 Reynolds J L, Joannides A J, Skepper J N. et al . Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations.  J Am Soc Nephrol. 2004;  15 2857-67
• 19 Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M. et al . The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.  J Clin Invest. 2003;  112 357-66
• 20 Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G. et al . Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.  Nephrol Dial Transplant. 2000;  15 218-23
• 21 Sigrist M K, Taal M W, Bungay P, McIntyre C W. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.  Clin J Am Soc Nephrol. 2007;  2 1241-8
• 22 Teng M, Wolf M, Ofsthun M N et al. Activated injectable vitamin D and hemodialysis survival.  J Am Soc Nephrol. 2005;  16 1115-25
• 23 US Renal Data System. USRDS 1999 annual data report.  Am J Kidney Dis. 1999;  34 (2 suppl 1) S87-S94
• 24 Young E W, Albert J M, Satayathum S, Goodkin D A, Pisoni R L, Akiba T. et al . Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.  Kidney Int. 2005;  67 1179-87